CRISPR Office Hours: How Biotech Companies Can Keep Calm and Carry On During the COVID-19 Crisis

CRISPR Office Hours with Jennifer Doudna, Ph.D.Подробнее

Keep Calm and CRISPR On During COVID-19: MIT EditionПодробнее

CRISPR Office Hours: How Coronavirus Will Disrupt Scientific ResearchПодробнее

Safely Maintaining Effective Biotech Operations and Research During COVID-19Подробнее

Breakthrough Economy: CRISPR Co-Founder Jennifer Doudna on CRISPR and the Future of BiotechПодробнее

Future of CRISPR TechnologyПодробнее

CRISPR Office Hours: How Genome Engineering Labs Adapt & Assist During the COVID-19 CrisisПодробнее

Fighting COVID-19 with CRISPR-Chip-Powered DiagnosticsПодробнее

Keep Calm and CRISPR On During COVID-19: Researchers are Raring to go!Подробнее

CRISPR explained by a PhD (in 20 seconds)Подробнее

CRISPR, Genetic Disease, and COVID-19Подробнее

Genome Engineering Using CRISPR TechnologyПодробнее

How Innovations in Genomics and Biotech Can Help Us With The COVID-19 CrisisПодробнее

CRISPR ExplainedПодробнее

Opening Remark: How CRISPR Impacts The Biotech IndustryПодробнее

Discovery Lecture | Dangerous Genes: From CRISPR Babies to the COVID-19 Lab Leak TheoryПодробнее

Keynote: How CRISPR Is Changing The Biotech IndustryПодробнее

Caspr Biotech developing cheap, rapid, point of care Crispr Cas12 Test | SOSVПодробнее

Professor Jennifer Doudna on CRISPR gene editing and COVID-19Подробнее